SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008571
Filing Date
2017-08-07
Accepted
2017-08-07 06:16:33
Documents
42
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 389972
2 ex31-1.htm EX-31.1 8972
3 ex31-2.htm EX-31.2 9034
4 ex32-1.htm EX-32.1 6880
  Complete submission text file 0001493152-17-008571.txt   1754125

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rttr-20170630.xml EX-101.INS 210151
6 XBRL SCHEMA FILE rttr-20170630.xsd EX-101.SCH 22205
7 XBRL CALCULATION FILE rttr-20170630_cal.xml EX-101.CAL 29357
8 XBRL DEFINITION FILE rttr-20170630_def.xml EX-101.DEF 71078
9 XBRL LABEL FILE rttr-20170630_lab.xml EX-101.LAB 174124
10 XBRL PRESENTATION FILE rttr-20170630_pre.xml EX-101.PRE 132633
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 171009924
SIC: 2834 Pharmaceutical Preparations